Immutep Limited
PRRUF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.37 | 0.39 | -0.40 | 0.35 |
| FCF Yield | -14.77% | -10.84% | -12.06% | -11.01% |
| EV / EBITDA | -5.64 | -3.81 | -4.34 | -6.17 |
| Quality | ||||
| ROIC | -86.87% | -46.05% | -56.35% | -36.62% |
| Gross Margin | -1,117.55% | -981.42% | 41.19% | -15,629.14% |
| Cash Conversion Ratio | 1.01 | 0.82 | 0.89 | 0.94 |
| Growth | ||||
| Revenue 3-Year CAGR | 12.89% | 182.52% | -3.18% | -71.66% |
| Free Cash Flow Growth | -73.68% | -0.89% | -17.14% | -71.35% |
| Safety | ||||
| Net Debt / EBITDA | 1.05 | 3.60 | 3.09 | 2.46 |
| Interest Coverage | 0.00 | -2,879.79 | -3,808.07 | -367.17 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -32.35 | 684.81 | -134.36 | 17,906.40 |